ACM
CNMD icon

Aster Capital Management’s CONMED CNMD Stock Holding History

Aster Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-571
Closed -$34.5K – 915
2026
Q1 		$34.5K Sell
571
-152
-21% -$6.18K 0.01% 491
2025
Q4 		$29.4K Buy
723
+581
+409% +$25.3K 0.01% 550
2025
Q3 		$6.68K Sell
142
-788
-85% -$40.9K ﹤0.01% 786
2025
Q2 		$48.4K Sell
930
-25
-3% -$1.37K 0.01% 609
2025
Q1 		$56.5K Buy
955
+901
+1,669% +$58.1K 0.01% 789
2024
Q4 		$3.7K Buy
+54
New +$3.76K ﹤0.01% 899

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Aster Capital Management's CNMD Position: Q2 2026 in Review

Aster Capital Management sold out of CONMED (CNMD) in Q2 2026, closing a stake of 571 shares — an estimated $34.5K sold.

Aster Capital Management first reported a position in CNMD in Q4 2024 and held it in 6 quarters. The position peaked at $56.5K in Q1 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Aster Capital Management reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 571 CONMED shares in Q2 2026, an estimated $34.5K.
  • Aster Capital Management first reported a position in CONMED in Q4 2024 and held it in 6 quarters.
  • Aster Capital Management's CONMED position peaked at $56.5K in Q1 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.